• Email
  • Help

This page brings together the Agency's latest information on cancer. It lists:

the ten newest and recently updated medicines authorised for the treatment of cancer in the European Union (EU);

the most recent opinions on anti-cancer medicines that are pending authorisation by the European Commission (EC);

the latest cancer-related news and press releases;

the Agency's events on cancer-related topics.

New and recently updated medicines

Opinions pending EC decision



  • 02/05/2012


    Workshop on health-related quality of life in oncology

    The workshop on health-related quality of life (HRQoL) in oncology aims to bring together relevant experts and discuss HRQoL issues with a focus on available instruments (including patient-reported outcomes [PRO]) and their utilisation in oncology clinical trials. The intention is to generate a HRQoL/PRO appendix to the anticancer medicines guideline. Registration by invitation only. ... Read more

  • 03/12/2010


    High-grade glioma expert group

    The European Medicines Agency is holding this expert meeting to understand and discuss how anti-cancer medicines should be developed to treat children with high-grade glioma, a disease with a dismal prognosis and high unmet needs. Recent biological and clinical data, as well as experience from paediatric trials, is being discussed. Preliminary consequences for paediatric trials and further questions are being identified. ... Read more